Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06105736 · ClinicalTrials.gov registry record · NA

Regulating Together in Tuberous Sclerosis Complex

A NA study of Behavioral Symptoms and TSC, sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
NA
Development phase
105
Enrollment target
2
Study locations

NCT06105736: Recruiting NA study of Behavioral Symptoms and TSC, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT06105736 is a NA study of Behavioral Symptoms and TSC that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 105 participants, below the 316-participant average among 6 other Behavioral Symptoms trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06105736, a NA study of Behavioral Symptoms and TSC, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
NA
Development phase
105 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to use a program called Regulating Together (RT), a remote, non-pharmacologic intervention to treat symptoms of emotion dysregulation in children and adolescents with Tuberous Sclerosis Complex (TSC) and TSC-Associated Neuropsychiatric Disorder (TAND).

Primary Outcome

Prevalence of emotion dysregulation is highly prevalent in TSC patients who exhibit problematic behaviors. The EDI-R score at the screening study visit will determine the EDI-R and determine the presence or absence of emotion dysregulation in the cohort.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Intervention in a small group platform

Study Locations (2)

North Carolina

  • University of North Carolina Chapel Hill-Carolina Institute for Developmental Disabilities - Carrboro

Ohio

  • Cincinnati Children's Hospital Medical Center (CCHMC) - Cincinnati

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2023-12-20
Est. Completion 2026-12-20
Phase NA

What NCT06105736 shows while recruiting

NCT06105736 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 316-participant average among 6 other Behavioral Symptoms trials with a reported enrollment target (67% lower).

The record links to 2 conditions, with Behavioral Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Intervention in a small group platform is the first listed.

NCT06105736 reports a single indexed study location in North Carolina, Ohio.

Frequently Asked Questions

What is clinical trial NCT06105736 about?

NCT06105736 is a clinical study titled "Regulating Together in Tuberous Sclerosis Complex". The purpose of this study is to use a program called Regulating Together (RT), a remote, non-pharmacologic intervention to treat symptoms of emotion dysregulation in children and adolescents with Tuberous Sclerosis Complex (TSC) and TSC-Associated Neuropsychiatric Disorder (TAND).

What is the current status of trial NCT06105736?

This trial is currently recruiting. It is a NA study. The enrollment target is 105 participants. The study started on 2023-12-20. Estimated completion is 2026-12-20.

What conditions does trial NCT06105736 study?

This clinical trial studies the following conditions: Behavioral Symptoms, TSC.

What interventions are being tested in trial NCT06105736?

The interventions under investigation include: Behavioral Intervention in a small group platform (BEHAVIORAL).

Who is sponsoring clinical trial NCT06105736?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06105736 being conducted?

This trial has 2 study locations across North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Behavioral Symptoms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06105736, the US trial registry maintained by the National Library of Medicine. NCT06105736 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.